Table 2. Comorbidities of obese and non-obese patients with presumed sepsis.
| Comorbidities | Obese (n = 573)a | Non-obese (n = 1,080)a | P valueb |
|---|---|---|---|
| Chronic pulmonary disease | 110 (19.2) | 161 (14.9) | 0.03 |
| Congestive heart failure | 118 (20.6) | 217 (20.1) | 0.81 |
| Diabetes mellitus | |||
| Without organ damage | 178 (31.1) | 209 (19.4) | <0.001 |
| With organ damagec | 77 (13.4) | 73 (6.8) | |
| Dialysis | 43 (7.5) | 78 (7.22) | 0.83 |
| Human immunodeficiency virus | 5 (0.87) | 11 (1.02) | 0.77 |
| Hypertension | |||
| Without chronic complications | 216 (37.7) | 349 (32.3) | <0.001 |
| With chronic complicationsd | 192 (33.5) | 289 (26.8) | |
| Leukemia/lymphoma | 114 (19.9) | 276 (25.6) | 0.01 |
| Liver disease | |||
| Mild | 60 (8.73) | 124 (11.5) | 0.1 |
| Moderate or severee | 47 (8.2) | 68 (6.3) | |
| Myocardial infarction | 82 (14.3) | 118 (10.9) | 0.05 |
| Solid tumor | |||
| Without metastasis | 40 (6.98) | 84 (7.78) | 0.17 |
| With metastasis | 50 (8.73) | 124 (11.5) | |
| Transplant (solid organ/hematopoietic stem cell) | 49 (8.55) | 153 (14.2) | <0.001 |
a
Data are presented as No. (%) of subjects
b
The χ2 test was used for categorical variables
c
Defined as neuropathy, retinopathy, or kidney disease
d
Defined as secondary causes of hypertension or associated kidney disease or congestive heart failure
e
Defined as liver disease with hepatic encephalopathy, ascites, esophageal varices, liver abscess or portal hypertension